Pflug Koory, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Pflug Koory, LLC

$1.4 Billion
Q1 2024

A detailed history of Pflug Koory, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Pflug Koory, LLC holds 1,078 shares of REGN stock, worth $767,967. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,078

Previous 1,083 0.46%

Holding current value

$767,967

Previous $951,000 9.04%

% of portfolio

0.07%

Previous 0.08%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	SELL	$902.69 - $993.35 $4,513 - $4,966	-5 Reduced 0.46%	1,078 $1.04 Million
Q4 2023 Jan 10, 2024	SELL	$775.18 - $881.7 $11,627 - $13,225	-15 Reduced 1.37%	1,083 $951,000
Q2 2023 Jul 21, 2023	SELL	$700.03 - $830.35 $10,500 - $12,455	-15 Reduced 1.35%	1,098 $788,000
Q1 2023 Apr 20, 2023	SELL	$680.49 - $826.97 $20,414 - $24,809	-30 Reduced 2.62%	1,113 $914,000
Q4 2022 Jan 18, 2023	SELL	$705.89 - $766.39 $2,117 - $2,299	-3 Reduced 0.26%	1,143 $825,000
Q3 2022 Oct 11, 2022	SELL	$573.97 - $724.32 $8,035 - $10,140	-14 Reduced 1.21%	1,146 $789,000
Q1 2021 Jul 13, 2021	SELL	$446.73 - $548.2 $13,848 - $16,994	-31 Reduced 2.6%	1,160 $549,000
Q4 2020 Jan 14, 2021	BUY	$478.3 - $607.98 $30,132 - $38,302	63 Added 5.59%	1,191 $575,000
Q3 2020 Oct 20, 2020	SELL	$544.75 - $658.21 $2,723 - $3,291	-5 Reduced 0.44%	1,128 $631,000
Q1 2020 Apr 24, 2020	BUY	$336.18 - $494.43 $210,112 - $309,018	625 Added 123.03%	1,133 $553,000
Q4 2019 Jan 14, 2020	BUY	$274.13 - $376.51 $139,258 - $191,267	508 New	508 $191,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pflug Koory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pflug Koory, LLC with notifications on news.

Account